News on this topic
U.S. FDA clears Omicron-specific COVID boosters, shots could begin within days: The U.S. on Wednesday authorized its first update to COVID-19 vaccines ...
globalnews.ca/news/9096938/covid-variant-booster-approval-us-fda/
US authorises Moderna, Pfizer-BioNTech COVID-19 vaccine boosters retooled for Omicron
channelnewsasia.com/world/us-authorises-moderna-pfizer-biontech-covid-19-vaccine-boosters-retool-omicron-2912876
FDA authorizes COVID-19 vaccine updates to fight most common omicron strain: The new U.S. boosters are combination, or "bivalent," shots. They contain half that ...
newsday.com/news/health/coronavirus/covid-vaccine-booster-omicron-update-approved-qqyzf8g9
More articles on this subject
Previous
U.S. FDA green lights Omicron-targeted COVID boosters ahead of revaccination campaign
reuters.com/business/healthcare-pharmaceuticals/us-authorizes-moderna-pfizerbiontech-vaccine-boosters-retooled-omicron-2022-08-31/
U.S. FDA clears Omicron-specific COVID boosters, shots could begin within days: The U.S. on Wednesday authorized its first update to COVID-19 vaccines ...
globalnews.ca/news/9096938/covid-variant-booster-approval-us-fda/
US authorises Moderna, Pfizer-BioNTech COVID-19 vaccine boosters retooled for Omicron
channelnewsasia.com/world/us-authorises-moderna-pfizer-biontech-covid-19-vaccine-boosters-retool-omicron-2912876
FDA authorizes COVID-19 vaccine updates to fight most common omicron strain: The new U.S. boosters are combination, or "bivalent," shots. They contain half that ...
newsday.com/news/health/coronavirus/covid-vaccine-booster-omicron-update-approved-qqyzf8g9
US FDA authorizes updated COVID boosters tailored to new subvariants: Following CDC approval, new 'bivalent' shots -- which are half the original ...
timesofisrael.com/us-fda-authorizes-updated-covid-boosters-tailored-to-new-subvariants/
US clears updated COVID boosters targeting newest variants: WASHINGTON (AP) — The United States (US) on Wednesday authorised its first update to COVID-19 ...
jamaicaobserver.com/latest-news/us-clears-updated-covid-boosters-targeting-newest-variants/
BioNTech with breakthrough - How is the stock reacting now?: BioNTech receives approval for the adapted corona vaccine. But what is the share doing now?
boerse-online.de/nachrichten/aktien/biontech-mit-durchbruch-wie-reagiert-jetzt-die-aktie--20316507.html
US Food and Drug Administration Gives Green Light to Omicron Vaccines: Two Vaccines Received Emergency Use Authorization from the FDA - also that of Biontech ...
allgemeine-zeitung.de/panorama/aus-aller-welt/us-arzneimittelbehorde-gibt-omikron-impfstoffen-grunes-licht_25694990
US Food and Drug Administration Gives Green Light to Omicron Vaccines: Two Vaccines Received Emergency Use Authorization from the FDA - also that of Biontech ...
oberhessische-zeitung.de/panorama/aus-aller-welt/us-arzneimittelbehorde-gibt-omikron-impfstoffen-grunes-licht_25694990
FDA Approves Omicron Vaccine by Pfizer and Moderan Even Without Human Trials: The vaccine boosters will target Omicron variant BA.4 and BA.5, which is expected ...
techtimes.com/articles/279920/20220831/pfizer-moderna-vaccines-against-omicron-variant-approved-fda.htm
FDA authorizes BA.4/5-targeting COVID boosters from Moderna and Pfizer: The new boosters are expected to start going into arms around Labor Day.
arstechnica.com/science/2022/08/fda-authorizes-omicron-targeting-covid-boosters-from-moderna-and-pfizer/
Omicron-specific vaccine boosters get FDA sign-off: The FDA authorized omicron-targeted booster doses of the Moderna and Pfizer / BioNTech COVID-19 vaccines ...
theverge.com/2022/8/31/23316414/omicron-vaccine-boosters-pfizer-moderna-fda-covid-19
Fragments of bird flu virus genome found in pasteurized milk, FDA says: The test cannot tell if the virus is live. FDA still considers milk supply safe.
arstechnica.com/uncategorized/2024/04/fda-finds-genetic-traces-of-bird-flu-virus-in-pasteurized-milk/
Why South Korean pop culture rocks and North Korea’s does not: Dictatorship stifles creativity and joy
economist.com/culture/2024/04/22/why-south-korean-pop-culture-rocks-and-north-koreas-does-not
Quick Glance: Kim Leads Rocket Drills for Nuclear Counterattacks
- North Korean leader Kim Jong Un supervised rocket launches simulating nuclear counterattacks.
- The drills showcased the strength of the country's nuclear forces.
- The rockets were described as highly accurate and capable of carrying tactical nuclear warheads.
- The US and South Korea are responding with enhanced military exercises and nuclear deterrence strategies.
US FDA sends warning letter to Cardinal Health for marketing unapproved devices
reut.rs/4bawEqO
Quick Glance: US FDA issues warning to Cardinal Health for marketing unauthorized devices
- Following an inspection of its facility in Illinois, the US health regulatory body issued a warning letter to Cardinal Health for marketing and distributing unauthorized devices from a Chinese manufacturer.
- In 2023, the U.S. Food and Drug Administration advised against using certain syringes manufactured in China due to reports of leaks, breakages, and quality issues, and recently expanded the guidelines.
- Cardinal has not responded to a request for comment from Reuters. The inspection revealed that Cardinal was importing two types of syringes under the Monoject brand.
- These syringes are utilized for injecting or withdrawing fluids from the body, as well as administering fluids or medications through a patient's feeding tube. In November, the agency cautioned healthcare providers and facilities against using Cardinal's Monoject syringes with pain management and syringe pumps.
Alzheimer's drug adoption in US slowed by doctors' skepticism: Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer's ...
reuters.com/business/healthcare-pharmaceuticals/alzheimers-drug-adoption-us-slowed-by-doctors-skepticism-2024-04-23/
Quick Glance: Alzheimer's Drug Uptake Hindered by Doctors' Skepticism in US
- The first drug to slow the progression of Alzheimer's, Leqembi by Eisai and Biogen, is facing resistance in the US from doctors who believe the treatment is futile.
- The requirements of Leqembi, such as additional diagnostic tests, twice-monthly infusions, and regular brain scans, have led to slow adoption as many doctors express concerns about efficacy, cost, and risks.
- Despite FDA approval and proven benefits in clinical trials, many doctors still have reservations about Leqembi, hindering the widespread use of the drug.
- The companies behind Leqembi are working to improve physician and patient education to increase acceptance of the medication, aiming to treat 100,000 patients by 2026.
Climate change is slowing Earth’s rotation: This simplifies things for the world’s timekeepers
economist.com/science-and-technology/2024/04/24/climate-change-is-slowing-earths-rotation
FDA Approves Antibiotic to Treat Urinary Infections: Pivmecillinam, which has been used in Europe for decades, will become available next year to women 18 and ...
nytimes.com/2024/04/24/health/fda-urinary-tract-infection-antibiotic.html
Why so many Chinese graduates cannot find work: Our number-crunching suggests that their plight could be much worse than previously thought
economist.com/china/2024/04/18/why-so-many-chinese-graduates-cannot-find-work
Paid articlePaid
Has Taylor Swift peaked?: The musician is at the height of her commercial, but not her creative, power
economist.com/culture/2024/04/24/has-taylor-swift-peaked
Merck raises 2024 profit forecast on surging sales of cancer drug Keytruda: Merck & Co on Thursday raised its annual profit and revenue forecasts on the back of ...
reuters.com/business/healthcare-pharmaceuticals/merck-raises-2024-profit-forecast-strong-cancer-hpv-drugs-sales-2024-04-25/
Quick Glance: Merck boosts 2024 profit outlook due to Keytruda sales
- Merck & Co. raises annual profit and revenue forecasts based on double-digit growth for the blockbuster cancer drug Keytruda.
- Sales for 2024 are estimated to be between $63.1 billion and $64.3 billion, an increase from the previous forecast.
- Keytruda recorded $6.95 billion in sales in the first quarter, a 20% increase from the previous year.
- Merck also saw strong growth with its vaccine Gardasil, the drug Vaxneuvance, and a successful acquisition of Harpoon Therapeutics in the first quarter of 2024.
India’s financial system has improved dramatically in the past decade : There is much more change to come
economist.com/special-report/2024/04/22/indias-financial-system-has-improved-dramatically-in-the-past-decade
Finally, America’s Congress does right by Ukraine: Disaster has been dodged. But the political malaise that delayed the Ukraine funding bill remains
economist.com/leaders/2024/04/20/finally-americas-congress-does-right-by-ukraine
One in Five Milk Samples Nationwide Shows Genetic Traces of Bird Flu: There is no evidence that the milk is unsafe to drink, scientists say. But the survey ...
nyti.ms/3xPK39o
What are the obligations of Israel and Hamas to protect civilians?: International Humanitarian Law creates obligations—but contains numerous caveats
economist.com/the-economist-explains/2024/04/24/what-are-the-obligations-of-israel-and-hamas-to-protect-civilians
US FDA approves ImmunityBio's bladder cancer therapy: The U.S. health regulator approved on Monday ImmunityBio's combination therapy to treat a type of bladder ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-immunitybios-bladder-cancer-therapy-2024-04-22/
Can anyone pull Boeing out of its nosedive?: The American planemaker needs one hell of a pilot
economist.com/business/2024/04/24/can-anyone-pull-boeing-out-of-its-nosedive
Solicitor General Elizabeth Prelogar again in the spotlight fighting the conservative Supreme Court on abortion
cnn.com/2024/04/24/politics/solicitor-general-elizabeth-prelogar-idaho-abortion/
Quick Glance: Supreme Court Divided on Emergency Abortion Access: Highlights
- The Supreme Court seems divided on access to emergency abortions in states with near-total bans.
- The 1986 Emergency Medical Treatment and Labor Act could impact abortion access in emergencies.
- The debate raises questions about fetal personhood and abortion rights conflict.
- The court's decision could affect abortion access in 14 states with strict abortion bans.
Biden administration issues privacy rule protecting abortion: President Joe Biden's administration issued a final rule on Monday aimed at strengthening privacy ...
reuters.com/world/us/biden-administration-issues-privacy-rule-protecting-abortion-2024-04-22/
Efforts to tackle student protests in America have backfired badly: Police intervention at Columbia has provoked protests at other universities
economist.com/united-states/2024/04/23/efforts-to-tackle-student-protests-in-america-have-backfired-badly
Don’t be gloomy about Tesla and its EV rivals : The industry has had a terrible few months. But demand is likely to pick up
economist.com/leaders/2024/04/24/dont-be-gloomy-about-tesla-and-its-ev-rivals
InnovationRx: Legislation Could Prevent Pharma Companies From Working With Chinese Contractors
forbes.com/sites/katiejennings/2024/04/17/innovationrx-legislation-could-prevent-pharma-companies-from-working-with-chinese-contractors/
“We have to make Biden lose”: Arab-Americans are switching to Trump: Anger over Gaza in the swing state of Michigan might cost the president the election
economist.com/1843/2024/04/24/we-have-to-make-biden-lose-arab-americans-are-switching-to-trump
Abeona shares tumble as FDA declines to approve skin disorder treatment: Abeona Therapeutics said on Monday the U.S. Food and Drug Administration (FDA) had ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-approve-abeonas-skin-disorder-treatment-2024-04-22/
National Drug Shortages Hit Record Levels : Requesting a refill at the local pharmacy or getting a complete series of a specific chemotherapy is becoming ...
webmd.com/drug-medication/news/20240418/national-drug-shortages-hit-record-levels
Eli Lilly to acquire manufacturing facility from Nexus Pharma: Eli Lilly said on Monday that it will acquire a manufacturing facility from Nexus Pharmaceuticals ...
reuters.com/business/healthcare-pharmaceuticals/eli-lilly-acquire-manufacturing-facility-nexus-pharma-2024-04-22/
How Russia targeted France and radicalised Emmanuel Macron: He is now one of Europe’s leading Russia hawks
economist.com/europe/2024/04/18/how-russia-targeted-france-and-radicalised-emmanuel-macron
Primary schools in Britain are beginning to close : A baby bust is starting to work its way through the system
economist.com/britain/2024/04/11/primary-schools-in-britain-are-beginning-to-close
Two years of war have impoverished many Ukrainians: The elderly, the displaced and the disabled are the worst affected
economist.com/europe/2024/04/21/two-years-of-war-have-impoverished-many-ukrainians
Gilead posts quarterly loss on acquisition charge, revenue rises 5%: Gilead Sciences reported a first-quarter loss on Thursday after taking a $3 ...
reuters.com/business/healthcare-pharmaceuticals/gilead-posts-quarterly-loss-revenue-rises-5-2024-04-25/
Congress tells China: sell TikTok or we’ll ban it: Only America’s courts can save the video app now
economist.com/business/2024/04/24/congress-tells-china-sell-tiktok-or-well-ban-it
Quick Glance: What Lies Ahead for TikTok in the US?
- The US Senate has unanimously approved a bill that could potentially lead to the banning of TikTok within nine months, unless its Chinese owner, ByteDance, withdraws from the video-sharing app due to concerns about national security threats.
- President Joe Biden has confirmed his intention to sign the legislation on Wednesday.
- ByteDance acquired the well-known karaoke app Musical.ly and rebranded it as TikTok back in 2017. It has become one of the fastest-growing applications in the United States, boasting 150 million monthly subscribers.
Reasons to be cheerful about Generation Z: They are not doomed to be poor and anxious
economist.com/leaders/2024/04/18/reasons-to-be-cheerful-about-generation-z
Israel should not rush to strike back at Iran: Instead it should try a novel response to Iran’s missile attack: restraint
economist.com/leaders/2024/04/18/israel-should-not-rush-to-strike-back-at-iran
Quick Glance: Israel artist calls for Gaza ceasefire
- The representative of Israel at the international art fair is calling for an immediate ceasefire in Israel’s war on Gaza.
- Ruth Patir’s video installation called (M)otherland was scheduled to open on Saturday at Israel’s national pavilion at the international art show but will remain closed for now.
- Patir stated on her website that the artist and curators are showing solidarity with the families of the hostages and the large community in Israel calling for change, rather than canceling themselves or the exhibition.
- It is believed that there are still individuals in Gaza, including 129 captives taken during the attacks led by Hamas on Israel on October 7, with 34 of them presumed dead.
Israel responds to Iran’s barrage with a symbolic strike: Both sides have a chance to de-escalate their conflict, at least for now
economist.com/middle-east-and-africa/2024/04/19/israel-responds-to-irans-barrage-with-a-symbolic-strike
Alzheimer’s drug Leqembi falls short of blockbuster status in faltering US rollout
ft.com/content/1e02c10c-f7c4-48e9-a6a4-774531b56350
Frozen Russian assets will soon pay for Ukraine’s war: And America now hopes to convince others to make better use of the stash
economist.com/finance-and-economics/2024/04/18/frozen-russian-assets-will-soon-pay-for-ukraines-war
Eli Lilly weight-loss drug found to address sleep apnoea in trial: Study results could encourage US Medicare system and private insurers to cover tirzepatide ...
ft.com/content/1c7e2db2-1bfd-4882-96d6-b53795844a1b
How Iran covered up the damage from Israel’s strikes: New images shared with The Economist show how a swap helped calm a crisis
economist.com/middle-east-and-africa/2024/04/24/how-iran-covered-up-the-damage-from-israels-strikes
The House of Representatives gives Ukraine its best news in a year: $61bn of aid is on the way. It should have an almost instant effect
economist.com/united-states/2024/04/20/the-house-of-representatives-just-gave-ukraine-the-best-news-it-has-had-for-a-year
Trump v Biden: who’s ahead in the latest polls?: The Economist is tracking the race to be America’s next president
economist.com/interactive/us-2024-election/trump-biden-polls
How to get more people into military uniforms: Why mandatory military service makes sense for some countries but not others
economist.com/leaders/2024/04/18/how-to-get-more-people-into-military-uniforms
Why the stockmarket is disappearing: Large companies such as ByteDance, OpenAI and Stripe are staying private
economist.com/finance-and-economics/2024/04/18/why-the-stockmarket-is-disappearing
Most of Lilly's Mounjaro and Zepbound doses in limited supply, FDA says: The U.S. Food and Drug Administration website showed that most doses of Eli Lilly's ...
reut.rs/4d1SgqR
Generation Z is unprecedentedly rich: Millennials were poorer at this stage in their lives. So were baby-boomers
economist.com/finance-and-economics/2024/04/16/generation-z-is-unprecedentedly-rich
Would you really die for your country?: Military conscription is on the agenda in the rich world
economist.com/international/2024/04/17/would-you-really-die-for-your-country
The growing role of fighting robots on the ground in Ukraine: Drones already fill the skies. Now uncrewed vehicles are heading to the front lines
economist.com/the-economist-explains/2024/04/19/the-growing-role-of-fighting-robots-on-the-ground-in-ukraine
Mayo Clinic RegenBio Summit 2024 registration opens, keynotes announced: Registration is open and keynote speakers for Mayo Clinic RegenBio Summit 2024 include ...
newsnetwork.mayoclinic.org/discussion/mayo-clinic-regenbio-summit-2024-registration-opens-keynotes-announced/
Who will lead the LVMH luxury empire?: Bernard Arnault sizes up his heirs apparent
economist.com/business/2024/04/18/who-will-lead-the-lvmh-luxury-empire
After Dobbs, Americans are turning to permanent contraception: More young women are tying their tubes
economist.com/graphic-detail/2024/04/19/after-dobbs-americans-are-turning-to-permanent-contraception
As Russia’s attacks step up, Ukraine fears waning Western support: An interview with the country’s new national security chief
economist.com/europe/2024/04/15/as-russias-attacks-step-up-ukraine-fears-waning-western-support
What to read to understand Chechnya: Four books and a film that unpack an influential region of Russia
economist.com/the-economist-reads/2024/04/16/what-to-read-to-understand-chechnya
Ukraine is ignoring US warnings to end drone operations inside Russia: Its superdrones can reach targets as far away as Siberia
economist.com/europe/2024/04/18/ukraine-is-ignoring-us-warnings-to-end-drone-operations-inside-russia
U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents: The U.S. Supreme Court on Monday declined to hear a bid by Vanda Pharmaceuticals ...
reuters.com/legal/us-supreme-court-rejects-vanda-pharmaceuticals-case-over-sleep-drug-patents-2024-04-22/
Without fanfare, the Philippines is getting richer: And its economy is unusually well-defended against American politics
economist.com/asia/2024/04/23/without-fanfare-the-philippines-is-getting-richer
Bogus Botox poisoning outbreak spreads to 9 states, CDC says: All of the case have been in women, nine of whom were hospitalized.
arstechnica.com/science/2024/04/bogus-botox-poisoning-outbreak-spreads-to-9-states-cdc-says/
A conservative strategist on how Joe Biden can win: Sarah Longwell says “double-haters” will decide the election
economist.com/by-invitation/2024/04/23/a-conservative-strategist-on-how-joe-biden-can-win
Quick Glance: Biden criticizes Florida's abortion ban and holds Trump accountable
- President Biden condemns the upcoming 6-week abortion ban in Florida.
- He blames Trump for appointing justices who overturned Roe v. Wade.
- Biden's campaign focuses on abortion rights to mobilize voters.
- Efforts to leverage Florida's abortion laws for political gain are highlighted.
What to read about India’s economy: Can it emulate China’s past manufacturing success—and should it even try?
economist.com/the-economist-reads/2024/04/22/what-to-read-about-indias-economy
The dark side of growing old: A coming wave of Alzheimer’s and other forms of dementia will test China to its limits
economist.com/china/2024/04/18/the-dark-side-of-growing-old
Paid articlePaid
Neumora's early-stage schizophrenia drug study put on hold: Neumora Therapeutics said on Monday the U.S. Food and Drug Administration (FDA) had placed a clinical ...
reut.rs/49wLNBq
What to read about the history of California: Five books that help explain the power and problems of the Golden State
economist.com/the-economist-reads/2024/04/25/what-to-read-about-the-history-of-california
Why is so much of the internet’s infrastructure run by volunteers?: Malware smuggled into XZ Utils software highlights a bigger problem
economist.com/the-economist-explains/2024/04/23/why-is-so-much-of-the-internets-infrastructure-run-by-volunteers
Truth Social is a mind-bending win for Donald Trump: And disturbing evidence of how he destabilises reality for Americans
economist.com/united-states/2024/04/18/truth-social-is-a-mind-bending-win-for-donald-trump
What happens if Ukraine loses?: Russian victory would be debilitating for the West, and especially for Europe
economist.com/europe/2024/04/11/what-happens-if-ukraine-loses
How Hollywood fell in love with video games: “Fallout” is the latest in a successful run of adaptations
economist.com/culture/2024/04/18/how-hollywood-fell-in-love-with-video-games
A short history of India in eight maps: Understanding the breathtaking diversity of India and Indians
economist.com/graphic-detail/2024/04/12/a-short-history-of-india-in-eight-maps
FDA classifies recall of Boston Scientific device as 'most serious': The U.S. Food and Drug Administration on Wednesday classified a recall of Boston ...
reuters.com/business/healthcare-pharmaceuticals/fda-classifies-recall-boston-scientific-device-treat-hemorrhaging-most-serious-2024-04-17/
Even without war in the Gulf, pricier petrol is here to stay: Expensive oil could put Donald Trump in the White House
economist.com/finance-and-economics/2024/04/17/even-without-war-in-the-gulf-pricier-petrol-is-here-to-stay
Iran and Israel’s shadow war explodes into the open: But the Islamic Republic may have miscalculated
economist.com/middle-east-and-africa/2024/04/14/iran-and-israels-shadow-war-explodes-into-the-open
3.6 million Medicare enrollees may now be eligible for Wegovy coverage: About 3.6 million Medicare enrollees may qualify for coverage for the anti-obesity drug ...
cnn.com/2024/04/24/health/wegovy-medicare-spending/
Käthe Kollwitz, a pioneering German artist, finally gets her due: Major exhibitions in Frankfurt and New York showcase her portrayals of the scars of war
economist.com/culture/2024/04/19/kathe-kollwitz-a-pioneering-german-artist-finally-gets-her-due
FDA and USDA food recalls reach highest level since before pandemic: Undeclared allergen, Listeria and Salmonella were the top three reasons for food recalls in ...
axios.com/2024/04/25/food-recall-usda-fda-recalls
The German chancellor’s awkward meeting with China’s boss: It is time for Xi Jinping to accept that Germany isn’t America’s puppet
economist.com/europe/2024/04/18/the-german-chancellors-awkward-meeting-with-chinas-boss
Ukrainian drone strikes are hurting Russia’s oil industry: The world’s third-largest producer is now an importer of petrol
economist.com/finance-and-economics/2024/04/11/ukrainian-drone-strikes-are-hurting-russias-oil-industry
Why do cicadas have such a strange life cycle?: Two broods will soon emerge simultaneously for the first time in 221 years
economist.com/the-economist-explains/2024/04/19/why-do-cicadas-have-such-a-strange-life-cycle
Citigroup, Wall Street’s biggest loser, is at last on the up: Jane Fraser’s unexpected success
economist.com/finance-and-economics/2024/04/18/citigroup-wall-streets-biggest-loser-is-at-last-on-the-up
On its 150th anniversary, Impressionism is surprisingly relevant: What the once-derided movement reveals about art today
economist.com/culture/2024/04/18/on-its-150th-anniversary-impressionism-is-surprisingly-relevant
US FDA warns of harmful reactions to fake Botox injections: The U.S. Food and Drug Administration on Tuesday alerted health care professionals and consumers that ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-warns-harmful-reactions-fake-botox-injections-2024-04-16/
We've started using a recently FDA-approved ultrasound device to treat liver tumors.
The noninvasive technology uses brief high-intensity ultrasound pulses to ...
cle.clinic/4askbih
The IDF is accused of military and moral failures in Gaza: Its generals botched the strategy, and discipline among troops has broken down
economist.com/middle-east-and-africa/2024/04/11/the-idf-is-accused-of-military-and-moral-failures-in-gaza
Tensions mount between China and the Philippines : The latest incident was just inside the “nine-dash line”
economist.com/asia/2024/04/18/tensions-mount-between-china-and-the-philippines
Next
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics